$INCY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INCYTE CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in INCYTE CORP. Get notifications about new insider transactions in INCYTE CORP for free.
Page: < prev 1 ... 14 15 16 17 18 19 20 21 21 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 05 2009 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 2.16 | 5 | 11 | 284,449 | 284.4 K to 284.4 K (0.00 %) |
Mar 05 2009 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 2.14 | 5 | 11 | 284,444 | 284.4 K to 284.4 K (0.00 %) |
Mar 05 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | P | 11.22 | 4,367,000 | 48,991,190 | 33,130,000 | |
Mar 05 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | P | 11.22 | 3,493,000 | 39,186,221 | 42,509,000 | |
Mar 05 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | P | 11.22 | 788,000 | 8,840,178 | 39,016,000 | |
Mar 05 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | P | 11.22 | 2,363,000 | 26,509,316 | 38,228,000 | |
Mar 05 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 2.16 | 11,232 | 24,233 | 7,081,505 | 7.1 M to 7.1 M (+0.16 %) |
Mar 05 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 2.14 | 9,524 | 20,397 | 7,070,273 | 7.1 M to 7.1 M (+0.13 %) |
Mar 05 2009 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Option Exercise | P | 11.22 | 121,000 | 1,357,439 | 989,000 | |
Mar 05 2009 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Option Exercise | P | 11.22 | 97,000 | 1,088,195 | 878,000 | |
Mar 05 2009 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Option Exercise | P | 11.22 | 22,000 | 246,807 | 781,000 | |
Mar 05 2009 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Option Exercise | P | 11.22 | 66,000 | 740,421 | 759,000 | |
Mar 05 2009 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 2.16 | 312 | 673 | 180,848 | 180.5 K to 180.8 K (+0.17 %) |
Mar 05 2009 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 2.14 | 264 | 565 | 180,536 | 180.3 K to 180.5 K (+0.15 %) |
Mar 02 2009 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | P | 11.22 | 4,000 | 44,872 | 332,000 | |
Mar 02 2009 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | P | 11.22 | 1,000 | 11,219 | 328,000 | |
Mar 02 2009 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | P | 11.22 | 2,000 | 22,437 | 327,000 | |
Mar 02 2009 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | P | 11.22 | 4,000 | 44,874 | 325,000 | |
Mar 02 2009 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 2.17 | 8 | 17 | 284,439 | 284.4 K to 284.4 K (0.00 %) |
Mar 02 2009 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 2.14 | 9 | 19 | 284,431 | 284.4 K to 284.4 K (0.00 %) |
Mar 02 2009 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 81,000 | 908,658 | 242,000 | |
Mar 02 2009 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 21,000 | 235,589 | 161,000 | |
Mar 02 2009 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 31,000 | 347,774 | 140,000 | |
Mar 02 2009 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 78,000 | 875,043 | 109,000 | |
Mar 02 2009 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 2.17 | 164 | 356 | 139,453 | 139.3 K to 139.5 K (+0.12 %) |
Mar 02 2009 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 2.14 | 179 | 382 | 139,289 | 139.1 K to 139.3 K (+0.13 %) |
Mar 02 2009 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 1,818,000 | 20,395,233 | 13,939,000 | |
Mar 02 2009 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 454,000 | 5,093,199 | 12,121,000 | |
Mar 02 2009 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 691,000 | 7,751,984 | 11,667,000 | |
Mar 02 2009 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 1,761,000 | 19,755,779 | 10,976,000 | |
Mar 02 2009 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 2.17 | 3,682 | 7,993 | 3,483,553 | 3.5 M to 3.5 M (+0.11 %) |
Mar 02 2009 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 2.14 | 4,019 | 8,587 | 3,479,871 | 3.5 M to 3.5 M (+0.12 %) |
Mar 02 2009 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Option Exercise | P | 11.22 | 219,000 | 2,456,852 | 638,000 | |
Mar 02 2009 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Option Exercise | P | 11.22 | 83,000 | 931,136 | 419,000 | |
Mar 02 2009 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Option Exercise | P | 11.22 | 212,000 | 2,378,322 | 336,000 | |
Mar 02 2009 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 2.17 | 443 | 962 | 180,272 | 179.8 K to 180.3 K (+0.25 %) |
Mar 02 2009 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 2.14 | 484 | 1,034 | 179,829 | 179.3 K to 179.8 K (+0.27 %) |
Mar 02 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | P | 11.22 | 7,878,000 | 88,379,343 | 33,896,000 | |
Mar 02 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | P | 11.22 | 2,993,000 | 33,576,971 | 26,018,000 | |
Mar 02 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | P | 11.22 | 7,627,000 | 85,563,500 | 23,025,000 | |
Mar 02 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 2.17 | 15,951 | 34,628 | 7,060,749 | 7 M to 7.1 M (+0.23 %) |
Mar 02 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 2.14 | 17,413 | 37,203 | 7,044,798 | 7 M to 7 M (+0.25 %) |
Jan 29 2009 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Option Exercise | A | 3.11 | 194,444 | 604,721 | 194,444 | |
Jan 29 2009 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Option Exercise | A | 3.11 | 5,556 | 17,279 | 5,556 | |
Jan 29 2009 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Option Exercise | A | 3.11 | 86,469 | 268,919 | 86,469 | |
Jan 29 2009 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Option Exercise | A | 3.11 | 13,531 | 42,081 | 13,531 | |
Jan 29 2009 | INCY | INCYTE CORP | METCALF BRIAN W | Chief Drug Discover ... | Option Exercise | A | 3.11 | 86,469 | 268,919 | 86,469 | |
Jan 29 2009 | INCY | INCYTE CORP | METCALF BRIAN W | Chief Drug Discover ... | Option Exercise | A | 3.11 | 13,531 | 42,081 | 13,531 | |
Jan 29 2009 | INCY | INCYTE CORP | SCHRECK PATRICIA A | EVP, General Counse ... | Option Exercise | A | 3.11 | 86,469 | 268,919 | 86,469 | |
Jan 29 2009 | INCY | INCYTE CORP | SCHRECK PATRICIA A | EVP, General Counse ... | Option Exercise | A | 3.11 | 13,531 | 42,081 | 13,531 | |
Jan 29 2009 | INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Off ... | Option Exercise | A | 3.11 | 86,469 | 268,919 | 86,469 | |
Jan 29 2009 | INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Off ... | Option Exercise | A | 3.11 | 13,531 | 42,081 | 13,531 | |
Jan 29 2009 | INCY | INCYTE CORP | Andrews Patricia S | Chief Commercial Of ... | Option Exercise | A | 3.11 | 97,220 | 302,354 | 97,220 | |
Jan 29 2009 | INCY | INCYTE CORP | Andrews Patricia S | Chief Commercial Of ... | Option Exercise | A | 3.11 | 2,780 | 8,646 | 2,780 | |
Jan 29 2009 | INCY | INCYTE CORP | Chardonnet Laurent | Option Exercise | A | 3.11 | 25,553 | 79,470 | 25,553 | ||
Jan 29 2009 | INCY | INCYTE CORP | Chardonnet Laurent | Option Exercise | A | 3.11 | 14,447 | 44,930 | 14,447 | ||
Jan 29 2009 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 3.11 | 61,096 | 190,009 | 61,096 | |
Jan 29 2009 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 3.11 | 13,904 | 43,241 | 13,904 | |
Jan 29 2009 | INCY | INCYTE CORP | Friedman Steven M. | EVP, Biology & Prec ... | Option Exercise | A | 3.11 | 61,096 | 190,009 | 61,096 | |
Jan 29 2009 | INCY | INCYTE CORP | Friedman Steven M. | EVP, Biology & Prec ... | Option Exercise | A | 3.11 | 13,904 | 43,241 | 13,904 | |
Dec 19 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 1,422,000 | 15,954,840 | 9,215,000 | |
Dec 19 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 2,383,000 | 26,737,260 | 2,383,000 | |
Dec 19 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 3.60 | 75,808 | 272,560 | 3,475,840 | 3.4 M to 3.5 M (+2.23 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 3.62 | 13,433 | 48,594 | 3,400,032 | 3.4 M to 3.4 M (+0.40 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 3.56 | 64,559 | 230,043 | 3,386,599 | 3.3 M to 3.4 M (+1.94 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 3.60 | 3,904 | 14,041 | 3,322,040 | 3.3 M to 3.3 M (+0.12 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 3.33 | 41,510 | 138,303 | 3,318,136 | 3.3 M to 3.3 M (+1.27 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 3.33 | 25,153 | 83,865 | 3,276,626 | 3.3 M to 3.3 M (+0.77 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 3.15 | 2,903 | 9,144 | 3,251,473 | 3.2 M to 3.3 M (+0.09 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 31,000 | 347,820 | 406,000 | |
Dec 19 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 52,000 | 583,440 | 52,000 | |
Dec 19 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 3.60 | 1,637 | 5,886 | 139,110 | 137.5 K to 139.1 K (+1.19 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 3.62 | 290 | 1,049 | 137,473 | 137.2 K to 137.5 K (+0.21 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 3.56 | 1,535 | 5,470 | 137,183 | 135.6 K to 137.2 K (+1.13 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 3.60 | 93 | 334 | 135,648 | 135.6 K to 135.6 K (+0.07 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 3.33 | 896 | 2,985 | 135,555 | 134.7 K to 135.6 K (+0.67 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 3.33 | 543 | 1,810 | 134,659 | 134.1 K to 134.7 K (+0.40 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 3.15 | 62 | 195 | 134,116 | 134.1 K to 134.1 K (+0.05 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | P | 11.22 | 6,000 | 67,320 | 74,000 | |
Dec 19 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | P | 11.22 | 11,000 | 123,420 | 11,000 | |
Dec 19 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 3.60 | 1,235 | 4,440 | 285,479 | 284.2 K to 285.5 K (+0.43 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 3.62 | 219 | 792 | 284,244 | 284 K to 284.2 K (+0.08 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 3.56 | 125 | 445 | 284,025 | 283.9 K to 284 K (+0.04 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 3.60 | 8 | 29 | 283,900 | 283.9 K to 283.9 K (0.00 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 3.33 | 184 | 613 | 283,892 | 283.7 K to 283.9 K (+0.06 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 3.33 | 112 | 373 | 283,708 | 283.6 K to 283.7 K (+0.04 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 3.15 | 13 | 41 | 283,596 | 283.6 K to 283.6 K (0.00 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | P | 11.22 | 4,534,000 | 50,871,480 | 34,127,000 | |
Dec 19 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | P | 11.22 | 7,598,000 | 85,249,560 | 7,598,000 | |
Dec 19 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 3.60 | 241,712 | 869,051 | 7,027,300 | 6.8 M to 7 M (+3.56 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 3.62 | 42,834 | 154,952 | 785,588 | 742.8 K to 785.6 K (+5.77 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 3.56 | 215,917 | 769,377 | 6,742,754 | 6.5 M to 6.7 M (+3.31 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 3.60 | 13,055 | 46,954 | 6,526,837 | 6.5 M to 6.5 M (+0.20 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 3.33 | 132,354 | 440,977 | 6,513,782 | 6.4 M to 6.5 M (+2.07 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 3.33 | 80,201 | 267,406 | 6,381,428 | 6.3 M to 6.4 M (+1.27 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 3.15 | 9,259 | 29,166 | 6,301,227 | 6.3 M to 6.3 M (+0.15 %) |
Dec 19 2008 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Option Exercise | P | 11.22 | 124,000 | 1,391,280 | 720,000 | |
Dec 19 2008 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Option Exercise | P | 11.22 | 206,000 | 2,311,320 | 206,000 | |
Dec 19 2008 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 3.60 | 6,602 | 23,737 | 179,342 | 172.7 K to 179.3 K (+3.82 %) |
Dec 19 2008 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 3.62 | 1,170 | 4,232 | 172,740 | 171.6 K to 172.7 K (+0.68 %) |
Dec 19 2008 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 3.56 | 5,897 | 21,013 | 171,570 | 165.7 K to 171.6 K (+3.56 %) |
Dec 19 2008 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 3.60 | 355 | 1,277 | 165,673 | 165.3 K to 165.7 K (+0.21 %) |
Dec 19 2008 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 3.33 | 3,616 | 12,048 | 165,318 | 161.7 K to 165.3 K (+2.24 %) |
Dec 19 2008 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 3.33 | 2,191 | 7,305 | 161,702 | 159.5 K to 161.7 K (+1.37 %) |
Dec 19 2008 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 3.15 | 254 | 800 | 159,511 | 159.3 K to 159.5 K (+0.16 %) |
Nov 24 2008 | INCY | INCYTE CORP | METCALF BRIAN W | Chief Drug Discover ... | Buy | P | 2.17 | 1,400 | 3,038 | 49,839 | 48.4 K to 49.8 K (+2.89 %) |
Nov 24 2008 | INCY | INCYTE CORP | METCALF BRIAN W | Chief Drug Discover ... | Buy | P | 2.18 | 300 | 654 | 48,439 | 48.1 K to 48.4 K (+0.62 %) |
Nov 24 2008 | INCY | INCYTE CORP | METCALF BRIAN W | Chief Drug Discover ... | Buy | P | 2.19 | 200 | 438 | 48,139 | 47.9 K to 48.1 K (+0.42 %) |
Nov 24 2008 | INCY | INCYTE CORP | METCALF BRIAN W | Chief Drug Discover ... | Buy | P | 2.20 | 3,100 | 6,820 | 47,939 | 44.8 K to 47.9 K (+6.91 %) |
Nov 21 2008 | INCY | INCYTE CORP | Chardonnet Laurent | Buy | P | 2.70 | 300 | 810 | 8,250 | 8 K to 8.3 K (+3.77 %) | |
Nov 21 2008 | INCY | INCYTE CORP | Chardonnet Laurent | Buy | P | 2.71 | 7,700 | 20,867 | 7,950 | 250 to 8 K (+3,080.00 %) | |
Nov 21 2008 | INCY | INCYTE CORP | SCHRECK PATRICIA A | EVP, General Counse ... | Buy | P | 2.44 | 2,500 | 6,100 | 4,500 | 2 K to 4.5 K (+125.00 %) |
Nov 21 2008 | INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Off ... | Buy | P | 2.36 | 4,000 | 9,440 | 6,500 | 2.5 K to 6.5 K (+160.00 %) |
Nov 21 2008 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Buy | P | 2.55 | 12,400 | 31,620 | 214,565 | 202.2 K to 214.6 K (+6.13 %) |
Nov 21 2008 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Buy | P | 2.55 | 600 | 1,527 | 202,165 | 201.6 K to 202.2 K (+0.30 %) |
Oct 23 2008 | INCY | INCYTE CORP | Andrews Patricia S | Chief Commercial Of ... | Option Exercise | A | 5.68 | 167,185 | 949,611 | 167,185 | |
Oct 23 2008 | INCY | INCYTE CORP | Andrews Patricia S | Chief Commercial Of ... | Option Exercise | A | 5.68 | 52,815 | 299,989 | 52,815 | |
Oct 16 2008 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Buy | P | 4.60 | 5,300 | 24,380 | 201,565 | 196.3 K to 201.6 K (+2.70 %) |
Oct 16 2008 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Buy | P | 5.35 | 2,800 | 14,980 | 196,265 | 193.5 K to 196.3 K (+1.45 %) |
Oct 16 2008 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Buy | P | 5.34 | 1,900 | 10,146 | 193,465 | 191.6 K to 193.5 K (+0.99 %) |
Aug 05 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 9.00 | 1,539 | 13,851 | 283,583 | 282 K to 283.6 K (+0.55 %) |
Aug 05 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 9.00 | 201,648 | 1,814,832 | 3,248,570 | 3 M to 3.2 M (+6.62 %) |
Aug 05 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 9.00 | 864,092 | 7,776,828 | 6,291,968 | 5.4 M to 6.3 M (+15.92 %) |
Aug 05 2008 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 9.00 | 27,724 | 249,516 | 159,257 | 131.5 K to 159.3 K (+21.08 %) |
Aug 05 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 9.00 | 4,997 | 44,973 | 134,054 | 129.1 K to 134.1 K (+3.87 %) |
May 22 2008 | INCY | INCYTE CORP | WHITFIELD ROY A | Director | Option Exercise | A | 9.92 | 20,000 | 198,400 | 20,000 | |
May 22 2008 | INCY | INCYTE CORP | DE SCHUTTER RICHARD U | Director | Option Exercise | A | 9.92 | 20,000 | 198,400 | 20,000 | |
May 22 2008 | INCY | INCYTE CORP | BROOKE PAUL A | Director | Option Exercise | A | 9.92 | 20,000 | 198,400 | 20,000 | |
May 22 2008 | INCY | INCYTE CORP | Emmens Matthew | Director | Option Exercise | A | 9.92 | 20,000 | 198,400 | 20,000 | |
May 22 2008 | INCY | INCYTE CORP | NIBLACK JOHN F | Director | Option Exercise | A | 9.92 | 20,000 | 198,400 | 20,000 | |
May 22 2008 | INCY | INCYTE CORP | BAKER JULIAN | Director | Option Exercise | A | 9.92 | 20,000 | 198,400 | 20,000 | |
May 22 2008 | INCY | INCYTE CORP | ARIKO BARRY A | Director | Option Exercise | A | 9.92 | 20,000 | 198,400 | 20,000 | |
Feb 11 2008 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Option Exercise | A | 11.98 | 191,653 | 2,296,003 | 191,653 | |
Feb 11 2008 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Chief Executive Off ... | Option Exercise | A | 11.98 | 8,347 | 99,997 | 8,347 | |
Feb 11 2008 | INCY | INCYTE CORP | METCALF BRIAN W | Chief Drug Discover ... | Option Exercise | A | 11.98 | 90,335 | 1,082,213 | 90,335 | |
Feb 11 2008 | INCY | INCYTE CORP | METCALF BRIAN W | Chief Drug Discover ... | Option Exercise | A | 11.98 | 9,665 | 115,787 | 9,665 | |
Feb 11 2008 | INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Off ... | Option Exercise | A | 11.98 | 90,335 | 1,082,213 | 90,335 | |
Feb 11 2008 | INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Off ... | Option Exercise | A | 11.98 | 9,665 | 115,787 | 9,665 | |
Feb 11 2008 | INCY | INCYTE CORP | KELLER JOHN A | Chief Business Offi ... | Option Exercise | A | 11.98 | 90,525 | 1,084,490 | 90,525 | |
Feb 11 2008 | INCY | INCYTE CORP | KELLER JOHN A | Chief Business Offi ... | Option Exercise | A | 11.98 | 9,475 | 113,511 | 9,475 | |
Feb 11 2008 | INCY | INCYTE CORP | Chardonnet Laurent | Option Exercise | A | 11.98 | 31,126 | 372,889 | 31,126 | ||
Feb 11 2008 | INCY | INCYTE CORP | Chardonnet Laurent | Option Exercise | A | 11.98 | 8,874 | 106,311 | 8,874 | ||
Feb 11 2008 | INCY | INCYTE CORP | SCHRECK PATRICIA A | EVP, General Counse ... | Option Exercise | A | 11.98 | 90,335 | 1,082,213 | 90,335 | |
Feb 11 2008 | INCY | INCYTE CORP | SCHRECK PATRICIA A | EVP, General Counse ... | Option Exercise | A | 11.98 | 9,665 | 115,787 | 9,665 | |
Feb 11 2008 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Option Exercise | A | 11.98 | 90,335 | 1,082,213 | 90,335 | |
Feb 11 2008 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Option Exercise | A | 11.98 | 9,665 | 115,787 | 9,665 | |
Jan 31 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | P | 11.22 | 48,000 | 538,488 | 365,000 | |
Jan 31 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | P | 11.22 | 2,000 | 22,437 | 317,000 | |
Jan 31 2008 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Option Exercise | P | 11.22 | 566,000 | 6,349,671 | 596,000 | |
Jan 31 2008 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Option Exercise | P | 11.22 | 26,000 | 291,681 | 30,000 |